Jennifer L Holter Chakrabarty
| Title | Prof |
|---|
| Institution | University of Oklahoma Health Sciences Center |
|---|
| Department | Medicine Hematology/Oncology |
|---|
| Address | SOCC 5 FL
800 NE 10th St
Oklahoma City OK 73104
|
|---|
| Phone | 405/271-4832 |
|---|
| vCard | Download vCard |
|---|
|
|
|
Research
R21CA271218 (HOLTER CHAKRABARTY, JENNIFER LIN)Jan 1, 2023 - Dec 31, 2024 NIH
Non-invasive assessment of graft vs host disease using optoacoustic imaging
Role: Principal Investigator |
|
R01HL146668 (HOLTER CHAKRABARTY, JENNIFER LIN;WILLIAMS, KIRSTEN)Sep 25, 2019 - Jul 31, 2024 NIH
Imaging and Blood Biomarkers to Predict Graft Failure after HSCT
Role: Principal Investigator |
Bibliographic
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Borogovac A, Keruakous A, Bycko M, Holter Chakrabarty J, Ibrahimi S, Khawandanah M, Selby GB, Yuen C, Schmidt S, Autry MT, Al-Juhaishi T, Wieduwilt MJ, Asch AS. Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center. Bone Marrow Transplant. 2022 06; 57(6):1025-1027.
PMID: 35411106.
Citations:
11 Fields:
Translation:
Humans
-
Williams KM, Wilson PT, Silva-Palacios F, Kebbe J, LaBeaud AD, Agudelo H, Sidonio RF, Stowell SR, Josephson CD, Tarini BA, Holter Chakrabarty JL, Agwu AL. COVID-19 Cliff Notes: A COVID-19 Multidisciplinary Care Compendium. Transplant Cell Ther. 2021 06; 27(6):474.e1-474.e3.
PMID: 33686384.
Citations:
1 Fields:
Translation:
HumansPHPublic Health
-
Schmidt S, Liu Y, Hu ZH, Williams KM, Lazarus HM, Vij R, Kharfan-Dabaja MA, Ortà G, Wiernik PH, Weisdorf D, Kamble RT, Herzig R, Wirk B, Cerny J, Bacher U, Chaudhri NA, Nathan S, Farhadfar N, Aljurf M, Gergis U, Szer J, Seo S, Hsu JW, Olsson RF, Maharaj D, George B, Hildebrandt GC, Agrawal V, Nishihori T, Abdel-Azim H, Alyea E, Popat U, Sobecks R, Scott BL, Holter Chakrabarty J, Saber W. The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era. Biol Blood Marrow Transplant. 2020 06; 26(6):1137-1143.
PMID: 32062061.
Citations:
3 Fields:
Translation:
HumansCells
-
Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018 06 10; 36(17):1714-1768.
PMID: 29442540.
Citations:
1307 Fields:
Translation:
Humans
-
Magome T, Froelich J, Takahashi Y, Arentsen L, Holtan S, Verneris MR, Brown K, Haga A, Nakagawa K, Holter Chakrabarty JL, Giebel S, Wong J, Dusenbery K, Storme G, Hui SK. Evaluation of Functional Marrow Irradiation Based on Skeletal Marrow Composition Obtained Using Dual-Energy Computed Tomography. Int J Radiat Oncol Biol Phys. 2016 11 01; 96(3):679-87.
PMID: 27681765.
Citations:
9 Fields:
Translation:
Humans
-
Wilke C, Holtan SG, Sharkey L, DeFor T, Arora M, Premakanthan P, Yohe S, Vagge S, Zhou D, Holter Chakrabarty JL, Mahe M, Corvo R, Dusenbery K, Storme G, Weisdorf DJ, Verneris MR, Hui S. Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimen. Radiother Oncol. 2016 Jan; 118(1):65-71.
PMID: 26653357.
Citations:
14 Fields:
Translation:
HumansCells
-
Price TH, Boeckh M, Harrison RW, McCullough J, Ness PM, Strauss RG, Nichols WG, Hamza TH, Cushing MM, King KE, Young JA, Williams E, McFarland J, Holter Chakrabarty J, Sloan SR, Friedman D, Parekh S, Sachais BS, Kiss JE, Assmann SF. Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. Blood. 2015 Oct 29; 126(18):2153-61.
PMID: 26333778.
Citations:
49 Fields:
Translation:
HumansCells
-
Khawandanah M, Gehrs B, Li S, Holter Chakrabarty J, Cherry M. A Case of Acute Myeloid Leukemia with a Previously Unreported Translocation (14; 15) (q32; q13). Case Rep Genet. 2014; 2014:921240.
PMID: 25436161.
Citations:
-
Khawandanah MO, Weiss SM, Cherry MA, Maymani H, Selby GB, Aster RH, George JN, Holter Chakrabarty JL. Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device. Transfusion. 2015 Mar; 55(3):657-60.
PMID: 25208591.
Citations: Fields:
Translation:
HumansAnimals
-
Holter Chakrabarty JL, Rubinger M, Le-Rademacher J, Wang HL, Grigg A, Selby GB, Szer J, Rowe JM, Weisdorf DJ, Tallman MS. Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission. Biol Blood Marrow Transplant. 2014 Jul; 20(7):1021-5.
PMID: 24691221.
Citations:
25 Fields:
Translation:
Humans
-
Holter JL, Thorp K, Smith ML, Kedzierska K, Fung KM, Chacko G, Swisher K, Epstein R, Gumerlock MK. [18F]fluorothymidine PET imaging in the diagnosis of leptomeningeal involvement with diffuse large B-cell lymphoma. Cancer Imaging. 2011 Sep 24; 11:140-3.
PMID: 22004872.
Citations:
4 Fields:
Translation:
Humans
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2011 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
Holter Chakrabarty's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(86)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_